Russia and Cuba to collaborate in biotechnology
This article was originally published in Scrip
Pharmapark andPharmstandard, two Russian companies that make biotechnological products for healthcare, have signed two memoranda with the Cuban centre for genetic engineering and biotechnology. The parties are expected to focus on the development and production of combined multifunctional vaccines in Russia. The agreements were made during a recent visit of a Russian government delegation to Havana.